+91 9784677044


Why Open Access?

The dissemination of scientific knowledge and the unrestricted use to further this knowledge should be available to all. High price should not become a barrier to researchers from under developed and developing countries. This is our basic objective and the reason to follow open access initiative.

Budapest Open Access Initiative

An old tradition and a new technology have converged to make possible an unprecedented public good. The old tradition is the willingness of scientists and scholars to publish the fruits of their research in scholarly journals without payment, for the sake of inquiry and knowledge. The new technology is the internet. The public good they make possible is the world-wide electronic distribution of the peer-reviewed journal literature and completely free and unrestricted access to it by all scientists, scholars, teachers, students, and other curious minds. Removing access barriers to this literature will accelerate research, enrich education, share the learning of the rich with the poor and the poor with the rich, make this literature as useful as it can be, and lay the foundation for uniting humanity in a common intellectual conversation and quest for knowledge.

(Source: http://www.budapestopenaccessinitiative.org/read)

Why it matters?

Research provides the foundation of modern society. Research leads to breakthroughs, and communicating the results of research is what allows us to turn breakthroughs into better lives to provide new treatments for disease, to implement solutions for challenges like global warming, and to build entire industries around what were once just ideas. However, our current system for communicating research is crippled by a centuries old model that hasn't been updated to take advantage of 21st century technology:

(Source: https://sparcopen.org/open-access/)

Licensing Policy

All the Vital Biotech, journals follow the creative commons license:

Creative Commons License
This work is licensed under a Creative
Commons Attribution 4.0 International License.

The updated copyright policy statement comes into effect on 1st June, 2018

As an open access journal Vital Biotech, Kota, Rajasthan, India follows the Creative Commons Attribution 4.0 International License which states that:

Share:  copy and redistribute the material in any medium or format

Adapt : remix, transform, and build upon the material for any purpose, even commercially.

Under the following terms:

Attribution : You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

No additional restrictions : You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Avoid Harm

With the advent of open access, also came the publishers with dubious reputation. This initiative is marred by unethical practices.

We at Vital Biotech, Kota, Rajasthan, identified the pitfalls and maintained the quality and reputation by following:

  • COPE policies and practices in our work flows
  • Strong double blind review policy
  • Plagiarism detection by Plagiarism Checker X version 6.0.11
  • Editorial board consisting of eminent academician and researches in the field of journal
  • Editorial board members contact and other details are available
  • Clear mention of Article Processing Charges
  • Strict adherence to policies which are mentioned on each journal's website